Contents
New Technology APC cost reporting tells Medicare what a hospital spends to furnish a complete new outpatient service, including labor, equipment, supplies and overhead. That estimate helps determine the service’s payment band while the Centers for Medicare & Medicaid Services gathers claims data. If you worked on the submission, supported the procedure or checked the hospital’s costs, you may know where the estimate came from and whether the description matches the work.
The question sits inside medical device reimbursement fraud: how information supplied by a manufacturer can reach a provider’s claim for government money. Here, the starting point is unusually concrete. The agency asks the applicant to describe both the service and the resources needed to deliver it, then put a cost beside them.
A New Technology APC covers a complete new service that existing codes and clinical payment groups cannot adequately accommodate. APC means Ambulatory Payment Classification, the grouping Medicare uses to pay for hospital outpatient services. A manufacturer, hospital or another interested party can request assignment for a new service.
The agency’s outpatient payment guide distinguishes these payments from device pass-through payments, which concern particular items used within a service. A new comprehensive service may qualify for a New Technology APC even when a device used in it could qualify for pass-through on its own.
The service must describe a distinct procedure with a beginning, middle and end. It can stand alone or accompany other procedures, but a tool, supply or integral component of an existing procedure does not become a complete service because the applicant gives it a new description. The agency can consider creating a HCPCS code when existing codes fail to capture the complete procedure and its resources.
The service must fit within Medicare’s benefits and meet the patient’s medical needs. Getting a payment group is separate from Medicare agreeing to cover the procedure for a particular patient. For someone reviewing a reimbursement presentation, that distinction matters whenever a payment code becomes a promise that Medicare will pay.
The hospital’s cost of furnishing the service is the number the agency asks the applicant to itemize. Its application requirements name labor, equipment, supplies and overhead. The accompanying clinical vignette describes the typical patient, diagnoses and resources used by both the facility and the physician.
For surgery, that description reaches staff, the operating room, recovery, equipment, supplies and devices. We compare the narrative with the calculation: which staff members are counted, how much time the estimate assigns them, which equipment the procedure uses and what supplies it consumes. A clinical employee who supports the procedure can explain the work behind a finance worksheet.
The finance comparison reaches the hospital’s underlying costs and the assumptions used to assign those costs to the service. If you know why the estimate uses a particular staffing level or overhead amount, that explanation belongs beside the submitted figure. We want to understand who supplied the number, what supported it and what the people reviewing it knew at the time.
The packet also asks where the service is performed and approximately how many patients receive it at each location. Those details let us put the cost estimate beside the experience the applicant described. A resource description drawn from an actual procedure and a projection for future use answer different questions about the basis for the estimate.
Food and Drug Administration approval or clearance information and evidence of clinical efficacy accompany the costs. The application also identifies the people responsible for the submission. An insider may know precisely where the clinical account and the financial calculation parted company.
The application identifies components already included in the proposed service and codes typically reported alongside it. The agency asks applicants to list the integral procedures and services that would represent unbundling if coded in addition to the new service. It separately asks for codes normally reported in addition, making the distinction explicit in the submission itself.
That gives us a direct comparison with manufacturer billing instructions. If a customer guide tells hospitals to bill a component separately, we compare that instruction with the integral-component list, the applicable payment rules and the hospital’s claims. The useful question is whether the claim sought extra payment for work already included in the complete service.
A separate device case shows why the customer worksheet belongs in that examination. The whistleblower complaint concerning Diopsys described an eye-testing workbook that combined clinical recommendations with the financial return to the provider:
The spreadsheet then lists a variety of “Clinical Indications” for which Diopsys recommends testing, provides diagnosis codes to utilize in connection with billing, and calculates the expected reimbursement to the provider.
United States ex rel. Jain v. Diopsys, Inc., whistleblower complaint, paragraph 49
The parallel is the manufacturer’s influence over the provider’s bill. For a New Technology APC inquiry, we would put that kind of worksheet beside what the applicant told CMS was already included. A document used to sell a device can also tell the customer how to ask Medicare for money.
Medicare assigns the service to a New Technology APC whose cost band includes the estimated cost of the service. The application packet explains that these groups are defined by cost, with payment based on the band’s midpoint. Clinical APCs group services by clinical characteristics and resource use. The new-technology band supplies a payment while the agency builds the claims history needed for that assignment.
The service stays in a New Technology APC until the agency has enough claims data to place it in an appropriate clinical group. Its guide describes this as generally two to three years, with reassignment depending on the available data.
The submitted estimate matters because it supplies a payment input before that claims history exists. If someone knowingly pads it to win a higher payment band, taxpayers pay for the padding. That is why we follow the assumptions back to the work.
Later claims introduce a different cost calculation. In its 2025 explanation of how it accounts for outpatient claims, the agency describes converting hospital charges into estimated resource costs using cost-to-charge ratios from hospital cost reports. Where possible, it applies the relevant department’s ratio to the charge, rather than the hospital’s overall ratio.
For an insider, the hospital’s cost estimate, its billed charges and Medicare’s calculated costs are separate numbers, shaped by different accounting methods. We trace an apparent difference back to the resources, dates and accounting method each number represents. The important comparison is what the applicant said the hospital would use, what supported that account and how the account affected government payment.
For a suspected false New Technology APC submission, we connect the application to hospital resources, billing instructions and claims for payment. The cost worksheet shows the submitted calculation. Clinical and finance records can explain its assumptions, while the code lists and customer guidance show how the described service was meant to reach a bill.
A finance employee may understand the cost allocation. A clinical employee may know whether the stated staff, room time or supplies match the procedure. Someone in market access or reimbursement may know which version went to CMS and which instructions went to customers. We work across those accounts to identify the representation, the people who knew its basis and the payment it influenced.
A 2020 analysis in the Journal of Forensic and Investigative Accounting, A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, centers the inquiry on the request for government money and whether a false statement induced wrongful payment. Applied here, that directs our attention from the application through the provider’s coding and billing to Medicare’s payment. We want the whole connection, including what the company knew when it supplied the information.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. For someone inside the business, the valuable knowledge may be why the submitted estimate or customer instruction differed from the work they knew the hospital performed. That is the conversation we can build on with you.
If you know how the hospital’s resources became the number sent to CMS, speak with our whistleblower experts about the submission and the billing it supported. We work with you to build your strongest medical device whistleblower case around that connection and bring in medical device fraud whistleblower lawyers who understand hospital reimbursement. We stay beside you as the financial assumptions, clinical work and claims come together.